285 related articles for article (PubMed ID: 11712810)
21. Levels of soluble Fas/APO-1 in patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
Mediators Inflamm; 1998; 7(2):111-4. PubMed ID: 9836498
[TBL] [Abstract][Full Text] [Related]
22. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
Nakae H; Narita K; Endo S
J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
[TBL] [Abstract][Full Text] [Related]
23. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity.
D'Auria L; Mussi A; Bonifati C; Mastroianni A; Giacalone B; Ameglio F
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):11-5. PubMed ID: 10188143
[TBL] [Abstract][Full Text] [Related]
24. High levels of TH2 cytokine gene expression in systemic lupus erythematosus.
Richaud-Patin Y; Alcocer-Varela J; Llorente L
Rev Invest Clin; 1995; 47(4):267-72. PubMed ID: 8525128
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
[TBL] [Abstract][Full Text] [Related]
26. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
Williams RC; Malone CC; Meyers C; Decker P; Muller S
J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
[TBL] [Abstract][Full Text] [Related]
27. Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.
Grzegorczyk J; Kowalski ML; Pilat A; Iwaszkiewicz J
Mediators Inflamm; 2002 Aug; 11(4):225-33. PubMed ID: 12396474
[TBL] [Abstract][Full Text] [Related]
28. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
29. Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus.
Robak E; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 1997 Sep; 8(3):281-6. PubMed ID: 9346362
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis.
Chan RW; Tam LS; Li EK; Lai FM; Chow KM; Lai KB; Li PK; Szeto CC
Arthritis Rheum; 2003 May; 48(5):1326-31. PubMed ID: 12746905
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus.
Al-Maini MH; Mountz JD; Al-Mohri HA; El-Ageb EM; Al-Riyami BM; Svenson KL; Zhou T; Richens ER
Lupus; 2000; 9(2):132-9. PubMed ID: 10787011
[TBL] [Abstract][Full Text] [Related]
32. Correlation of serum measures of nitric oxide production with lupus disease activity.
Gilkeson G; Cannon C; Oates J; Reilly C; Goldman D; Petri M
J Rheumatol; 1999 Feb; 26(2):318-24. PubMed ID: 9972965
[TBL] [Abstract][Full Text] [Related]
33. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families.
Gröndal G; Kristjansdottir H; Gunnlaugsdottir B; Arnason A; Lundberg I; Klareskog L; Steinsson K
Arthritis Rheum; 1999 Aug; 42(8):1649-54. PubMed ID: 10446864
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.
Linker-Israeli M; Deans RJ; Wallace DJ; Prehn J; Ozeri-Chen T; Klinenberg JR
J Immunol; 1991 Jul; 147(1):117-23. PubMed ID: 2051017
[TBL] [Abstract][Full Text] [Related]
35. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
37. Increased CCR4 expression in active systemic lupus erythematosus.
Hase K; Tani K; Shimizu T; Ohmoto Y; Matsushima K; Sone S
J Leukoc Biol; 2001 Nov; 70(5):749-55. PubMed ID: 11698495
[TBL] [Abstract][Full Text] [Related]
38. The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis.
Kamper EF; Kopeikina LT; Trontzas P; Potamianou A; Tsiroglou E; Stavridis JC
J Rheumatol; 2000 Nov; 27(11):2545-50. PubMed ID: 11093432
[TBL] [Abstract][Full Text] [Related]
39. Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
Miret C; Font J; Molina R; Filella X; Vivancos J; Muñoz-Rodriguez FJ; Cervera R; Ballesta AM; Ingelmo M
Anticancer Res; 1998; 18(2B):1341-4. PubMed ID: 9615813
[TBL] [Abstract][Full Text] [Related]
40. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
